River Wealth Advisors LLC Amgen Inc Transaction History

River Wealth Advisors LLC

  • $740 Million
  • Q3 2024

A detailed history of River Wealth Advisors LLC transactions in Amgen Inc stock. As of the latest transaction made, River Wealth Advisors LLC holds 14,480 shares of AMGN stock, worth $4.26 Million. This represents 0.63% of its overall portfolio holdings.

Number of Shares
14,480
Previous 14,822 2.31%
Holding current value
$4.26 Million
Previous $4.63 Million 0.73%
% of portfolio
0.63%
Previous 0.67%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$309.38 - $337.38 $105,807 - $115,383
-342 Reduced 2.31%
14,480 $4.67 Million
Q2 2024

Aug 13, 2024
SELL
$262.75 - $319.31 $12,612 - $15,326
-48 Reduced 0.32%
14,822 $4.63 Million
Q1 2024

May 14, 2024
SELL
$268.87 - $324.56 $122,604 - $147,999
-456 Reduced 2.98%
14,870 $4.23 Million
Q4 2023

Feb 13, 2024
SELL
$255.7 - $288.46 $227,828 - $257,017
-891 Reduced 5.49%
15,326 $4.41 Million
Q3 2023

Nov 13, 2023
SELL
$218.65 - $271.46 $188,913 - $234,541
-864 Reduced 5.06%
16,217 $4.36 Million
Q2 2023

Aug 09, 2023
SELL
$214.27 - $253.37 $84,422 - $99,827
-394 Reduced 2.25%
17,081 $3.79 Million
Q1 2023

May 11, 2023
SELL
$225.79 - $275.2 $163,471 - $199,244
-724 Reduced 3.98%
17,475 $4.22 Million
Q4 2022

Feb 10, 2023
SELL
$229.03 - $291.01 $78,786 - $100,107
-344 Reduced 1.86%
18,199 $4.78 Million
Q3 2022

Nov 14, 2022
SELL
$224.46 - $253.15 $196,626 - $221,759
-876 Reduced 4.51%
18,543 $4.18 Million
Q2 2022

Aug 10, 2022
SELL
$230.71 - $256.74 $179,261 - $199,486
-777 Reduced 3.85%
19,419 $4.73 Million
Q1 2022

May 09, 2022
BUY
$219.27 - $242.57 $118,186 - $130,745
539 Added 2.74%
20,196 $4.88 Million
Q4 2021

Feb 11, 2022
BUY
$198.88 - $227.6 $994 - $1,138
5 Added 0.03%
19,657 $4.42 Million
Q3 2021

Nov 12, 2021
BUY
$212.27 - $248.7 $138,187 - $161,903
651 Added 3.43%
19,652 $4.18 Million
Q2 2021

Aug 06, 2021
BUY
$233.58 - $259.14 $113,753 - $126,201
487 Added 2.63%
19,001 $4.63 Million
Q1 2021

May 11, 2021
BUY
$221.91 - $258.6 $39,278 - $45,772
177 Added 0.97%
18,514 $4.61 Million
Q4 2020

Feb 16, 2021
BUY
$216.38 - $257.67 $239,532 - $285,240
1,107 Added 6.42%
18,337 $4.22 Million
Q3 2020

Nov 10, 2020
BUY
$234.65 - $260.95 $143,136 - $159,179
610 Added 3.67%
17,230 $4.38 Million
Q2 2020

Aug 11, 2020
BUY
$197.81 - $242.74 $94,948 - $116,515
480 Added 2.97%
16,620 $3.92 Million
Q1 2020

May 05, 2020
BUY
$182.24 - $241.7 $192,992 - $255,960
1,059 Added 7.02%
16,140 $3.27 Million
Q4 2019

Feb 07, 2020
SELL
$189.21 - $243.2 $342,280 - $439,948
-1,809 Reduced 10.71%
15,081 $3.64 Million
Q3 2019

Oct 29, 2019
BUY
$174.11 - $208.62 $416,993 - $499,644
2,395 Added 16.52%
16,890 $3.27 Million
Q2 2019

Jul 30, 2019
BUY
$166.7 - $195.41 $99,686 - $116,855
598 Added 4.3%
14,495 $2.67 Million
Q1 2019

May 07, 2019
SELL
$180.87 - $203.88 $309,468 - $348,838
-1,711 Reduced 10.96%
13,897 $2.64 Million
Q4 2018

Jan 25, 2019
BUY
$178.4 - $208.25 $266,529 - $311,125
1,494 Added 10.59%
15,608 $3.04 Million
Q3 2018

Nov 09, 2018
SELL
$185.29 - $208.89 $193,442 - $218,081
-1,044 Reduced 6.89%
14,114 $2.93 Million
Q2 2018

Aug 13, 2018
SELL
$166.05 - $186.51 $4,815 - $5,408
-29 Reduced 0.19%
15,158 $2.8 Million
Q1 2018

May 02, 2018
BUY
$169.43 - $198.0 $45,068 - $52,668
266 Added 1.78%
15,187 $2.59 Million
Q4 2017

Feb 09, 2018
BUY
$168.79 - $188.59 $61,777 - $69,023
366 Added 2.51%
14,921 $2.6 Million
Q3 2017

Nov 06, 2017
BUY
$167.29 - $191.0 $2.43 Million - $2.78 Million
14,555
14,555 $2.71 Million

Others Institutions Holding AMGN

# of Institutions
3,122
Shares Held
410M
Call Options Held
7.56M
Put Options Held
7.2M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track River Wealth Advisors LLC Portfolio

Follow River Wealth Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of River Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on River Wealth Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email